technescan sestamibi 1 mg radiofarmaceitiskais komplekts (kits)
curium netherlands b.v., netherlands - [tetrakis(2-metoksi-2-metilpropil-1-isocyanid)varš(1+)] tetrafluoroboratum - komplekts radiofarmaceitiskā preparāta pagatavošanai - 1 mg
l-thyroxin berlin-chemie 150 mikrogramu tabletes
berlin-chemie ag (menarini group), germany - levotiroksīna nātrija sāls - tablete - 150 μg
l-thyroxin berlin-chemie 100 mikrogramu tabletes
berlin-chemie ag (menarini group), germany - levotiroksīna nātrija sāls - tablete - 100 μg
l-thyroxin berlin-chemie 50 mikrogramu tabletes
berlin-chemie ag (menarini group), germany - levotiroksīna nātrija sāls - tablete - 50 μg
l-thyroxin berlin-chemie 125 mikrogramu tabletes
berlin-chemie ag (menarini group), germany - levotiroksīna nātrija sāls - tablete - 125 μg
l-thyroxin berlin-chemie 75 mikrogramu tabletes
berlin-chemie ag (menarini group), germany - levotiroksīna nātrija sāls - tablete - 75 μg
euthyrox 25 mikrogrami tabletes
merck serono, sia, latvia - levotiroksīna nātrija sāls - tablete - 25 μg
euthyrox 100 mikrogrami tabletes
merck serono, sia, latvia - levotiroksīna nātrija sāls - tablete - 100 μg
citalopram-teva 10 mg apvalkotās tabletes
teva pharma b.v., netherlands - citaloprāms - apvalkotās tabletes - 10 mg
lumykras
amgen europe bv - sotorasib - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.